会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • Astrocyte modulated genes and uses thereof
    • 星形胶质细胞调节基因及其用途
    • US20050172343A1
    • 2005-08-04
    • US10975280
    • 2004-10-27
    • Paul FisherZhao-zhong SuDong-chul Kang
    • Paul FisherZhao-zhong SuDong-chul Kang
    • A01K67/027C07H21/04C07K14/47C12N5/06C12N7/00C12N15/12C12Q1/70
    • C07K14/47
    • The present invention relates to Astrocyte Modulated Genes (AMGs). AMGs are genes whose expression are modulated in human astrocytes grown in primary cell culture following the exposure of these cells to either the human immunodeficiency virus HIV-1 or to the HIV-1 protein gp120. AMGs comprise both Astrocyte Enhanced Genes (AEGs) and Astrocyte Suppressed Genes (ASGs). Thus, the present invention further relates to Astrocyte Enhanced Genes (AEGs), the expression of which are up-regulated in human astrocytes grown in primary cell culture that are exposed to either the human immunodeficiency virus HIV-1 or to the HIV-1 protein gp120, and to Astrocyte Suppressed Genes (ASGs), the expression of which are downregulated in human astrocytes grown in primary cell culture that are exposed to either the human immunodeficiency virus HIV-1 or to the HIV-1 protein gp120. Because they may play a role in HIV-associated dementia (“HAD”), AMGs may be used as markers in methods for screening for drugs that treat or prevent HAD.
    • 本发明涉及星形胶质细胞调节基因(AMG)。 AMG是在将这些细胞暴露于人免疫缺陷病毒HIV-1或HIV-1蛋白gp120后在原代细胞培养物中生长的人星形胶质细胞中表达的基因。 AMGs包括星形胶质细胞增强基因(AEG)和星形胶质细胞抑制基因(ASGs)。 因此,本发明还涉及星形胶质细胞增强型基因(AEG),其表达在暴露于人类免疫缺陷病毒HIV-1或HIV-1蛋白的原代细胞培养物中生长的人星形胶质细胞中上调 gp120,以及星形胶质细胞抑制基因(ASG),其表达在暴露于人体免疫缺陷病毒HIV-1或HIV-1蛋白gp120的原代细胞培养物中生长的人星形胶质细胞中下调。 因为它们可能在HIV相关性痴呆(“HAD”)中发挥作用,AMGs可用作筛选治疗或预防HAD的药物的方法中的标记。
    • 2. 发明申请
    • Astrocyte Modulated Genes And Uses Thereof
    • 星形胶质细胞调控基因及其用途
    • US20090203885A1
    • 2009-08-13
    • US12422882
    • 2009-04-13
    • Paul B. FisherZhao-zhong SuDong-chul Kang
    • Paul B. FisherZhao-zhong SuDong-chul Kang
    • C07K14/16
    • C07K14/47
    • The present invention relates to Astrocyte Modulated Genes (AMGs). AMGs are genes whose expression are modulated in human astrocytes grown in primary cell culture following the exposure of these cells to either the human immunodeficiency virus HIV-1 or to the HIV-1 protein gp120. AMGs comprise both Astrocyte Enhanced Genes (AEGs) and Astrocyte Suppressed Genes (ASGs). Thus, the present invention further relates to Astrocyte Enhanced Genes (AEGs), the expression of which are up-regulated in human astrocytes grown in primary cell culture that are exposed to either the human immunodeficiency virus HIV-1 or to the HIV-1 protein gp120, and to Astrocyte Suppressed Genes (ASGs), the expression of which are downregulated in human astrocytes grown in primary cell culture that are exposed to either the human immunodeficiency virus HIV-1 or to the HIV-1 protein gp120. Because they may play a role in HIV-associated dementia (“HAD”), AMGs may be used as markers in methods for screening for drugs that treat or prevent HAD.
    • 本发明涉及星形胶质细胞调节基因(AMG)。 AMG是在将这些细胞暴露于人免疫缺陷病毒HIV-1或HIV-1蛋白gp120后在原代细胞培养物中生长的人星形胶质细胞中表达的基因。 AMGs包括星形胶质细胞增强基因(AEG)和星形胶质细胞抑制基因(ASGs)。 因此,本发明还涉及星形胶质细胞增强型基因(AEG),其表达在暴露于人类免疫缺陷病毒HIV-1或HIV-1蛋白的原代细胞培养物中生长的人星形胶质细胞中上调 gp120,以及星形胶质细胞抑制基因(ASG),其表达在暴露于人类免疫缺陷病毒HIV-1或HIV-1蛋白gp120的原代细胞培养物中生长的人星形胶质细胞中下调。 因为它们可能在HIV相关性痴呆(“HAD”)中发挥作用,AMGs可用作筛选治疗或预防HAD的药物的方法中的标记。
    • 3. 发明申请
    • Human excitatory amino acid transporter-2 gene promoter and uses thereof
    • 人兴奋性氨基酸转运蛋白-2基因启动子及其用途
    • US20060127980A1
    • 2006-06-15
    • US11197226
    • 2005-08-04
    • Paul FisherZhao-zhong Su
    • Paul FisherZhao-zhong Su
    • A61K38/17C07K14/705C07H21/04C12N5/08C12P21/06
    • C07K14/705
    • The nucleic acid sequence of the human Excitatory Amino Acid Transporter-2 Gene (hEAAT2) promoter, a nucleic acid sequence that hybridizes to the hEAAT2 promoter nucleic acid sequence under stringent hybridization conditions, and a nucleic acid sequence that is functionally equivalent to the hEAAT2 promoter sequence are provided, as are vectors containing these nucleic acid sequences. In addition, methods for the use of these nucleic acids to achieve tissue- or cell-specific gene expression are provided, as are methods for the use of these hEAAT2 promoter nucleic acids to identify agents that can modulate glutamate transport or the activity of the glutamate promoter. Such agents may be useful in the prevention, palliation or treatment of neurodegenerative and/or cerebrovascular diseases.
    • 人激动性氨基酸转运蛋白-2基因(hEAAT2)启动子的核酸序列,在严格杂交条件下与hEAAT2启动子核酸序列杂交的核酸序列以及在功能上等同于hEAAT2启动子的核酸序列 提供了序列,以及含有这些核酸序列的载体。 此外,提供了使用这些核酸实现组织或细胞特异性基因表达的方法,以及使用这些hEAAT2启动子核酸鉴定可调节谷氨酸转运或谷氨酸活性的试剂的方法 启动子。 这样的药剂可用于预防,缓解或治疗神经变性和/或脑血管疾病。